About us

About Mordelt Healthcare

Deploying technology, products, and investment to close the primary care gap across the UK and West Africa.

Part of something larger

Mordelt Healthcare is a subsidiary of Mordelt Group, operating alongside Mordelt Capital to deploy technology, products, and investment across healthcare.

Mordelt Group is the parent holding company. Mordelt Capital is the investment and capital deployment arm. Mordelt Healthcare is the healthcare-focused subsidiary responsible for building the AI platform, distributing essential medicines, and directing strategic investment into Healthcare IT and medtech.

Mordelt Group
Mordelt Healthcare
AI platform, medicines,
healthcare investments
Mordelt Capital
Investment and capital
deployment

Three integrated arms

Our business is structured around three reinforcing pillars: an AI-powered care platform, a generic medicines distribution arm, and a strategic healthcare investment practice.

01

AI Platform

AI-powered primary care triage and chronic disease management. Clinical decision support, ambient documentation, and workflow automation for the highest-volume areas of care delivery.

02

Products

Generic medicines distribution focused on metabolic health: diabetes, hypertension, and obesity. Serving fragmented pharmaceutical supply chains across West Africa and the UK.

03

Investments

Strategic capital deployment into Healthcare IT and medtech. Healthcare IT deal value doubled in 2025 to $32B. 46% of healthcare VC flows into AI. Women's health is an investment arbitrage opportunity.

UK and West Africa

The UK provides a proven regulatory and digital health playbook. West Africa has over 400 million people underserved by primary care infrastructure, massive prevalence of metabolic diseases, and highly fragmented pharmaceutical supply chains. The combination offers a tested model and a vast addressable market.

London

United Kingdom

Headquarters and platform development. Regulatory base for UK market operations and investment origination.

Lagos

Nigeria

Medicines distribution hub and primary care AI deployment across Nigeria's 220 million population.

Accra

Ghana

West African expansion base. Growing distribution network and market access across the region.

Let's talk

Whether you're a healthcare provider, pharmaceutical distributor, technology partner, or investor, we'd like to hear from you.